The Mitochondrial Ca2+ Uniporter (MCU) Complex: A Key Regulator In Cardiovascular Disease

Calcium (Ca²⁺) is a crucial signaling molecule that significantly influences various cellular processes, including mitochondrial respiration, ATP production, and autophagy. Within the mitochondria, Ca²⁺ enters through the mitochondrial Ca²⁺ uniporter (MCU), which is a low-affinity, high-capacity ion channel driven by the negative membrane potential. This uptake of Ca²⁺ is essential for regulating ATP synthesis, primarily by activating calcium-dependent dehydrogenases. Under both resting and stress conditions, the MCU aligns mitochondrial energy production with the increased demands of cardiac cells, particularly in terms of contractility and Ca2+ handling. Dysregulation of the MCU has been linked to several cardiovascular diseases. For instance, its deletion has been shown to reduce myocardial injury during ischemia-reperfusion (I/R) events by preventing Ca2+ overload, mitochondrial dysfunction, and oxidative stress. In contrast, during heart failure (HF) and cardiac hypertrophy, moderate overexpression of the MCU has been found to enhance cardiac contractility, while excessive expression can lead to mitochondrial Ca2+ overload, worsening oxidative damage. The regulatory subunits of the MCU complex, including the MICU1-MICU2 complex and the essential MCU regulator (EMRE), play crucial roles in maintaining Ca2+ homeostasis. MICU proteins function as gatekeepers, regulating calcium influx in response to cytosolic Ca2+ levels, while EMRE is crucial for the structural and functional integrity of the MCU. Targeting these subunits could offer a promising therapeutic strategy for managing cardiovascular diseases. Overall, the regulatory functions of the MCU and potential pharmacological or molecular interventions targeting mitochondrial Ca2+ homeostasis are crucial for maintaining cardiac health and preventing the progression of cardiovascular disorders.